SpineAlign Medical, Inc. Announces VerteLift(TM) European Registry Initiation

Published: Sep 13, 2010

SAN JOSE, Calif.--(BUSINESS WIRE)--SpineAlign Medical, Inc. announced today that it has enrolled its initial patient in the European Observational Registry for the VerteLift System, an observation study to further assess the ability of the VerteLift System to treat the pain and dysfunction associated with osteoporotic vertebral compression fractures (VCF), while providing clinically measurable height restoration based upon previous European experience and analysis. On August 30th, Dr. Frank Hassel, Loretto-Hospital, Freiburg Germany surgically treated the first patient in the multi-center observation registry. VerteLift is SpineAlign’s first CE Mark product in commercial release outside the US. It is a transpedicular, minimally invasive approach to reduction, stabilization and pain relief associated with vertebral compression fractures.

Back to news